Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
A trial of AZD9833 for breast cancer (SERENA-4) | Cancer Research UK
Estudio de AZD9833 y un inhibidor de CDK4/6 en pacientes con cáncer de ...
Abstract OT2-11-06: SERENA-4: A Phase III comparison of AZD9833 ...
阿斯利康乳腺癌新药 AZD9833 国内获批临床 2 月 20 日，CDE 官网显示， 阿斯利康 的雌激素受体拮抗剂 AZD9833 首次在 ...
Chemical structure of AZD3293. | Download Scientific Diagram
乳腺癌新药：阿斯利康 AZD9833 在国内启动临床，口服 SERD医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Camizestrant (AZD9833) | Estrogen Receptor Antagonist | CAS 2222844-89 ...
阿斯利康口服SERD乳腺癌II期研究成功 10月26日， 阿斯利康 宣布，其下一代口服选择性雌激素受体降解剂（SERD ...
Camizestrant, AZD 9833 « New Drug Approvals
Camizestrant (AZD-9833) | CAS 2222844-89-3 | AbMole BioScience ...
Camizestrant (AZD-9833) | CAS#2222844-89-3 MCE貨號HY-136255
ACS Medicinal Chemistry Letters | Vol 11, No 12
Figure 1 from Addition of Fluorine and a Late-Stage Functionalization ...
Discovery of AZD9833, a potent and orally bioavailable selective ...
Addition of Fluorine and a Late-Stage Functionalization (LSF) of the ...
新药研发：阿斯利康临床I期ER降解剂&拮抗剂AZD9833的发现|阿斯利康|降解剂|拮抗剂|化合物|乳腺癌|细胞株|-健康界
Buy Other Targets | Life Sciences - Ligands Products | Biosynth
口服ER降解剂：4大制药巨头竞技，谁能鱼和熊掌兼得？医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
The Next-Generation Oral Selective Estrogen Receptor Degrader ...
ISSX 2022 - Hypha Discovery
AZD-9833 is an Orally Active Estrogen Receptor (ER) Antagonist ...
camizestrant (AZD9833) / AstraZeneca
G1T48 is a potent selective estrogen receptor downregulator (SERD). a ...
Study on the Effects and Safety of Camizestrant (AZD9833) Compared to ...
AZD-9833 (Camizestrant); Estrogen receptor antagonist 2 - 小分子，大梦想
Camizestrant (AZD-9833) | Estrogen Receptor Antagonist | MedChemExpress
Emerging ADC Targets: B7-H3 and B7-H4
阿斯利康第二代PARP1抑制剂AZD5305联合AZD9833治疗BRCA或PALB2突变的晚期乳腺癌患者 - 知乎
CAMBRIA-2: An Adjuvant Endocrine-based Therapy Study of Camizestrant ...
Illustration of the drug camizestrant (AZD9833). Camizestrant is an ...
Chemspace | Analogs to New Biological Tool Compounds | Camizestrant ...
AD9833 Configuration AD9833 Programmed via 3-wire through a high-speed ...
Welcome to Hodoodo Chemicals
Frontiers | Optimization of small molecule degraders and antagonists ...
AZD8330 | MEK inhibitor | CAS 869357-68-6 | Selleck
外设驱动库开发笔记4：AD9833函数发生器驱动_ad9833输出方波-CSDN博客
Abstract P3-07-13: The next generation oral selective estrogen receptor ...
AD9833: A versatile easy to use signal generator on a chip
Abstract 5674: Discovery of AZD9833, an oral small molecule selective ...
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC ...
Chemical structures of compound AZD-3293. a AZD-3289 is a potent BACE1 ...
Oxidized Metabolites and Unusual Conjugates of AZD9496 - Hypha Discovery
AZD-5462 | Selleck Chemicals
tilatamig samrotecan (AZD9592) / AstraZeneca
接轨国际，阿斯利康一日两款1类新药国内申请临床医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
AZD2389 | Immunology & Inflammation related inhibitor | CAS 2791472-12 ...
AD9833 undocumented parts of the datasheet - Q&A - Direct Digital ...
Targeting Breast Cancer: An Overlook on Current Strategies - PMC
Prediction of Camizestrant human PK from integration of ADME studies ...
Ten Ways Degraders Differentiate from Traditional Small Molecules
AZD-1305 | Antiarrhythmic Agent | MedChemExpress
Coumestrol | 拟雌内酯 | Estrogen/progestogen Receptor 化学品 | 现货供应 | 美国品牌 ...
AZD-3199 dihydrobromide | TargetMol
